FR2353549A1 - Nouvelles prostaglandines, leur preparation et leur application comme medicaments - Google Patents

Nouvelles prostaglandines, leur preparation et leur application comme medicaments

Info

Publication number
FR2353549A1
FR2353549A1 FR7706181A FR7706181A FR2353549A1 FR 2353549 A1 FR2353549 A1 FR 2353549A1 FR 7706181 A FR7706181 A FR 7706181A FR 7706181 A FR7706181 A FR 7706181A FR 2353549 A1 FR2353549 A1 FR 2353549A1
Authority
FR
France
Prior art keywords
preparation
application
medicinal products
new prostaglandins
prostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7706181A
Other languages
English (en)
French (fr)
Inventor
Roland Wenger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2353549A1 publication Critical patent/FR2353549A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR7706181A 1976-04-27 1977-03-03 Nouvelles prostaglandines, leur preparation et leur application comme medicaments Withdrawn FR2353549A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH526876 1976-04-27

Publications (1)

Publication Number Publication Date
FR2353549A1 true FR2353549A1 (fr) 1977-12-30

Family

ID=4290745

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7706181A Withdrawn FR2353549A1 (fr) 1976-04-27 1977-03-03 Nouvelles prostaglandines, leur preparation et leur application comme medicaments
FR7726295A Withdrawn FR2355837A1 (fr) 1976-04-27 1977-08-30 Nouvelles prostaglandines, leur preparation et leur application comme medicaments

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7726295A Withdrawn FR2355837A1 (fr) 1976-04-27 1977-08-30 Nouvelles prostaglandines, leur preparation et leur application comme medicaments

Country Status (13)

Country Link
JP (1) JPS52131600A (xx)
BE (1) BE852055A (xx)
DE (1) DE2707915A1 (xx)
DK (1) DK75177A (xx)
FI (1) FI770572A (xx)
FR (2) FR2353549A1 (xx)
GB (1) GB1577647A (xx)
IL (1) IL51561A0 (xx)
NL (1) NL7702221A (xx)
NZ (1) NZ183462A (xx)
PT (1) PT66269B (xx)
SU (1) SU741794A3 (xx)
ZA (1) ZA771215B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds

Also Published As

Publication number Publication date
PT66269B (en) 1978-11-07
DK75177A (da) 1977-10-28
BE852055A (fr) 1977-09-05
DE2707915A1 (de) 1977-11-17
NZ183462A (en) 1979-10-25
JPS52131600A (en) 1977-11-04
ZA771215B (en) 1978-10-25
IL51561A0 (en) 1977-04-29
PT66269A (en) 1977-04-01
FI770572A (xx) 1977-10-28
FR2355837A1 (fr) 1978-01-20
GB1577647A (en) 1980-10-29
NL7702221A (nl) 1977-10-31
SU741794A3 (ru) 1980-06-15

Similar Documents

Publication Publication Date Title
BE859067A (fr) Nouveaux amino-ethers peptidiques, leur preparation et leur application comme medicaments
BE860049A (fr) Nouveaux benzamides substitues utilisables comme medicaments
FR2349566A1 (fr) Nouvelles (1-naphtylalkyl)-amines, leur preparation et leur application comme medicaments
BE865624A (fr) Interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
BE854072A (fr) Nouvelles aminopiperidines, leur preparation et leur emploi comme medicament
FR2353540A1 (fr) Nouveaux benzamides applicables comme medicaments
FR2308361A1 (fr) Nouvelles 3,4-dihydrospiro-2h-1,3-benzoxazines utiles comme medicaments
IT1085949B (it) 2-benzil-pirrolidine,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2339590A1 (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
FR2303560A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
BE874683A (fr) Nouveaux derives bicyclo-octaniques leur preparation et leur utilisation comme medicaments
LU77548A1 (fr) ((quinolyl-4)-3 propyl-1)-4piperidines,leur preparation et leur utilisation comme medicaments
FR2275200A1 (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
FR2316949A1 (fr) Derives du benzo-cyclohepta-thiophene, leur preparation et leur application comme medicaments
FR2342065A1 (fr) Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments
BE856899A (fr) Nouveaux composes polypeptidiques, leur preparation et leur application comme medicaments
BE862038A (fr) 1-amino-alkyl inferieur-3,4-diphenyl-1h-pyrazoles et leur utilisation comme medicaments
BE863007A (fr) Nouvelles arylenedioxy-bis-dicetones, leur preparation et leur utilisation comme medicaments
BE858887A (fr) Nouveaux perhydro-indolinols, leur preparation et leur application comme medicaments
FR2322594A1 (fr) Nouvelles 2,3-trans-methylene-15-hydroxy-prostaglandines, leur preparation et leur application comme medicaments
FR2353549A1 (fr) Nouvelles prostaglandines, leur preparation et leur application comme medicaments
FR2303545A1 (fr) Nouvelles pyridones, leur preparation et leur application comme medicaments
BE867339A (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
BE862303A (fr) Nouvelles 0-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
BE855484A (fr) Nouvelles pyridones, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse